| Literature DB >> 29849898 |
Nikolai Engedal1, Eva Žerovnik2, Alexander Rudov3, Francesco Galli4, Fabiola Olivieri5,6, Antonio Domenico Procopio5,6, Maria Rita Rippo5, Vladia Monsurrò7, Michele Betti3, Maria Cristina Albertini3.
Abstract
Oxidative stress can alter the expression level of many microRNAs (miRNAs), but how these changes are integrated and related to oxidative stress responses is poorly understood. In this article, we addressed this question by using in silico tools. We reviewed the literature for miRNAs whose expression is altered upon oxidative stress damage and used them in combination with various databases and software to predict common gene targets of oxidative stress-modulated miRNAs and affected pathways. Furthermore, we identified miRNAs that simultaneously target the predicted oxidative stress-modulated miRNA gene targets. This generated a list of novel candidate miRNAs potentially involved in oxidative stress responses. By literature search and grouping of pathways and cellular responses, we could classify these candidate miRNAs and their targets into a larger scheme related to oxidative stress responses. To further exemplify the potential of our approach in free radical research, we used our explorative tools in combination with ingenuity pathway analysis to successfully identify new candidate miRNAs involved in the ubiquitination process, a master regulator of cellular responses to oxidative stress and proteostasis. Lastly, we demonstrate that our approach may also be useful to identify novel candidate connections between oxidative stress-related miRNAs and autophagy. In summary, our results indicate novel and important aspects with regard to the integrated biological roles of oxidative stress-modulated miRNAs and demonstrate how this type of in silico approach can be useful as a starting point to generate hypotheses and guide further research on the interrelation between miRNA-based gene regulation, oxidative stress signaling pathways, and autophagy.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29849898 PMCID: PMC5932428 DOI: 10.1155/2018/4968321
Source DB: PubMed Journal: Oxid Med Cell Longev ISSN: 1942-0994 Impact factor: 6.543
Common gene targets of microRNAs with possible role in oxidative stress. Common targets of 13 oxidative stress-modulated miRNAs: hsa-let7f (91 elements), hsa-miR-9 (936 elements), hsa-miR-16 (294 elements), hsa-miR-21 (105 elements), hsa-miR-22 (330 elements), hsa-miR-29b (158 elements), hsa-miR-99a (24 elements), hsa-miR-125b (412 elements), hsa-miR-128 (785 elements), hsa-miR-143 (263 elements), hsa-miR-144 (647 elements), hsa-miR-155 (281 elements), and hsa-miR-200c (34 elements). Listed are 13 gene targets found to be common to 5, 6, or 7 of the 13 oxidative stress-modulated miRNAs. The database used for this analysis was TargetScan [13]. The miRNA-target genes marked in italics have already been validated and described to be involved in oxidative stress responses.
| Target gene | Annotation | Common miRNAs |
|---|---|---|
| ZNF618 | Zinc finger protein 618 | hsa-miR-9; hsa-miR-22; hsa-miR-125b; hsa-miR-128; hsa-miR-143; hsa-miR-144; hsa-miR-155 |
| SH3PXD2A | SH3 and PX domains 2A | hsa-miR-9; hsa-miR-22; hsa-miR-29b; hsa-miR-143; hsa-miR-144; hsa-miR-155 |
| TNRC6B | Trinucleotide repeat containing 6B | hsa-miR-9; hsa-miR-16; hsa-miR-29b; hsa-miR-128; hsa-miR-144; hsa-miR-22 |
| CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | let-7f; hsa-miR-9; hsa-miR-22; hsa-miR-143; hsa-miR-155 |
| CPEB3 | Cytoplasmic polyadenylation element binding protein 3 | hsa-miR-9; hsa-miR-16; hsa-miR-21; hsa-miR-128; hsa-miR-144 |
|
| Peroxisome proliferator-activated receptor alpha | hsa-miR-9; hsa-miR-22; hsa-miR-21; hsa-miR-128; hsa-miR-144 |
| CLCN5 | Chloride channel 5 (nephrolithiasis 2, X-linked, Dent disease) | hsa-miR-9; hsa-miR-16; hsa-miR-22; hsa-miR-128; hsa-miR-155 |
|
| CDC14 cell division cycle 14 homolog B ( | hsa-miR-9; hsa-miR-16; hsa-miR-125b; hsa-miR-128; hsa-miR-144 |
| LIFR | Leukemia inhibitory factor receptor alpha | hsa-miR-9; hsa-miR-143; hsa-miR-21; hsa-miR-128; hsa-miR-144 |
| KCNA1 | Potassium voltage-gated channel, shaker-related subfamily, member 1 (episodic ataxia with myokymia) | hsa-miR-9; hsa-miR-155; hsa-miR-21; hsa-miR-128; hsa-miR-144 |
| USP31 | Ubiquitin-specific peptidase 31 | hsa-miR-9; hsa-miR-16; hsa-miR-155; hsa-miR-200c; hsa-miR-144 |
| tcag7.1228 | Hypothetical protein FLJ25778 | hsa-miR-9; hsa-miR-16; hsa-miR-21; hsa-miR-128; hsa-miR-144 |
|
| Nuclear factor I/B | hsa-miR-9; hsa-miR-22; hsa-miR-21; hsa-miR-128; hsa-miR-29b |
Note: see Supplementary Table 1 for this table in Excel format, and see Supplementary Table 2 for a full list of gene targets found to be common to ≥2 of the 13 oxidative stress-modulated miRNAs (i.e., all possible combinations).
Common pathways (KEGG) of microRNAs associated with oxidative stress. Common pathways (KEGG pathway IDs) of hsa-let7f (129 elements), hsa-miR-9 (140 elements), hsa-miR-16 (117 elements), hsa-miR-21 (64 elements), hsa-miR-22 (101 elements), hsa-miR-29b (126 elements), hsa-miR-99a (40 elements), hsa-miR-125b (126 elements), hsa-miR-128 (103 elements), hsa-miR-143 (80 elements), hsa-miR-144 (110 elements), hsa-miR-155 (70 elements), and hsa-miR-200c (113 elements). The pathways are common to all the 13 oxidative stress-modulated miRNAs. The KEGG pathway name (first column), the gene symbols involved in each pathway (second column), and the ID of the pathway used by the KEGG database (third column) are indicated. The database used for this analysis was DIANA-MicroT 3.0 [3].
| KEGG pathway name | Gene symbol | KEGG pathway ID |
|---|---|---|
| MAPK signaling pathway | FGF12, PRKCA, MAP3K1, RPS6KA4, SOS1, MAP3K3, SRF, PAK2, MAP2K7, FGF18, RAP1B, MAPKAPK2, ACVR1B, TGFBR2, FGF5, DUSP6, ACVR1C, PDGFRB | hsa04010 |
| Melanoma | FGF12, FGF18, FGF5, CDH1, IGF1, PDGFRB, PIK3R3, PDGFC | hsa05218 |
| Colorectal cancer | RALGDS, SOS1, TCF7, ACVR1B, TGFBR2, ACVR1C, DCC, PDGFRB, PIK3R3, SMAD4 | hsa05210 |
| Glioma | PRKCA, SHC2, SOS1, SHC1, IGF1, PDGFRB, PIK3R3 | hsa05214 |
| Adherens junction | CTNNA1, ACTN2, VCL, TCF7, BAIAP2, SRC, ACVR1B, SSX2IP, TGFBR2, ACVR1C, CDH1, SMAD4 | hsa04520 |
| Focal adhesion | ITGB4, PRKCA, SHC2, ACTN2, TNC, DIAPH1, VCL, COL5A1, ITGA6, SOS1, VAV3, SHC1, SRC, PAK4, PAK2, PAK6, THBS2, RAP1B, IGF1, PDGFRB, PIK3R3, PDGFC | hsa04510 |
| TGF-beta signaling pathway | ID4, SMURF1, INHBB, THBS2, ACVR1B, TGFBR2, ACVR1C, SMAD4 | hsa04350 |
| mTOR signaling pathway | TSC1, ULK2, IGF1, PIK3R3, EIF4E | hsa04150 |
| Prostate cancer | CCNE2, SOS1, TCF7, FOXO1, CREB5, IGF1, PDGFRB, PIK3R3, PDGFC, CREB3L2 | hsa05215 |
| Wnt signaling pathway | WNT4, PRKCA, TCF7, VANGL1, PSEN1, PPARD, SMAD4 | hsa04310 |
| Cytokine-cytokine receptor interaction | LEP, CNTFR, LIFR, CXCL11, INHBB, KITLG, TNFRSF21, ACVR1B, TGFBR2, PDGFRB, PDGFC | hsa04060 |
| Basal cell carcinoma | WNT4, TCF7, PTCH1 | hsa05217 |
| Type II diabetes mellitus | SOCS4, PIK3R3 | hsa04930 |
| Cell adhesion molecules (CAMs) | SDC2, CLDN14, SDC1, NFASC, ITGA6, NEO1, ALCAM, NLGN2, CDH1 | hsa04514 |
| Regulation of actin cytoskeleton | ITGB4, MYH9, FGF12, ACTN2, DIAPH1, VCL, ARPC1A, ARHGEF7, PIP4K2B, ITGA6, SOS1, VAV3, BAIAP2, DIAPH2, PAK4, PAK2, PAK6, FGF18, FGF5, SLC9A1, PDGFRB, PIK3R3 | hsa04810 |
| Long-term potentiation | PRKCA, RAP1B | hsa04720 |
| Insulin signaling pathway | TSC1, SHC2, SOCS4, CBL, SOS1, FOXO1, SHC1, PIK3R3, EIF4E | hsa04910 |
| Leukocyte transendothelial migration | CTNNA1, PRKCA, ACTN2, CLDN14, VCL, VAV3, RAP1B, PIK3R3 | hsa04670 |
| Tight junction | CTNNA1, MYH9, PPP2R4, PRKCA, ACTN2, CLDN14, AMOTL1, SRC, CSDA | hsa04530 |
| Axon guidance | SRGAP3, PLXNA2, NTNG1, EPHB2, SEMA6D, EPHA7, NRP1, PAK4, PAK2, PAK6, DCC, EPHB4, EFNA1 | hsa04360 |
| Calcium signaling pathway | PRKCA, SLC8A1, ADCY9, PDGFRB | hsa04020 |
| T cell receptor signaling pathway | CBL, SOS1, VAV3, PAK4, PAK2, PAK6, PIK3R3 | hsa04660 |
| GnRH signaling pathway | PRKCA, MAP3K1, SOS1, MAP3K3, SRC, ADCY9, MAP2K7 | hsa04912 |
| ErbB signaling pathway | PRKCA, SHC2, CBL, SOS1, SHC1, SRC, ABL2, PAK4, PAK2, PAK6, MAP2K7, PIK3R3 | hsa04012 |
| Acute myeloid leukemia | SOS1, TCF7, JUP, PPARD, PIK3R3 | hsa05221 |
| VEGF signaling pathway | PRKCA, SHC2, SRC, MAPKAPK2, PIK3R3 | hsa04370 |
Note: see Supplementary Table 3 for this table in Excel format, and see Supplementary Table 4 for a full list of all KEGG pathways common to ≥2 of the 13 oxidative stress-modulated miRNAs.
Figure 1Simplified flow diagram indicating the interrelation between pathways predicted to be commonly modified by the 13 oxidative stress-related miRNAs considered in this study.
miRNAs predicted to be involved in oxidative stress responses. Identification of miRNAs predicted to simultaneously target the genes identified in Table 1: ZNF618 (114 elements), SH3PXD2A (135 elements), TNRC6B (329 elements), CBL (740 elements), CPEB3 (178 elements), PPARA (933 elements), CLCN5 (167 elements), CDC14B (64 elements), LIFR (553 elements), KCNA1 (549 elements), USP31 (93 elements), tcag7.1228 (210 elements), and NFIB (281 elements). Shown are miRNAs (column 1) common to ≥9 of the 13 gene targets with the corresponding annotation. We found one miRNA (hsa-miR-9) common to all 13 gene targets. The database used for this analysis was TargetScan [13]. The miRNAs marked in italics have already been described to be involved in oxidative stress response.
| Common miRNAs | Target genes |
|---|---|
|
| CBL; CPEB3; PPARA; CLCN5; CDC14B; LIFR; KCNA1; USP31; ZNF618; tcag7.1228; NFIB; SH3PXD2A; TNRC6B |
| hsa-miR-548c-3p | CBL; CPEB3; PPARA; CDC14B; LIFR; KCNA1; USP31; ZNF618; tcag7.1228; NFIB; SH3PXD2A; TNRC6B |
|
| CBL; CPEB3; PPARA; CLCN5; CDC14B; LIFR; KCNA1; ZNF618; tcag7.1228; NFIB; TNRC6B |
| hsa-miR-655 | CBL; CPEB3; LIFR; KCNA1; USP31; ZNF618; tcag7.1228; NFIB; SH3PXD2A; TNRC6B |
| hsa-miR-195 | CBL; CPEB3; PPARA; CLCN5; CDC14B; KCNA1; USP31; tcag7.1228; TNRC6B |
Note: see Supplementary Table 5 for this table in Excel format, and see Supplementary Table 6 for a full list of miRNAs that target ≥2 of the 13 gene targets.
Figure 2MicroRNAs predicted to target genes involved in the pathways modulated by oxidative stress. We added to the previous simplified flow diagram (shown in Figure 1) the miRNAs that we predicted to be putative novel actors in oxidative stress responses (shown in Table 3) and grouped them according to their common gene targets and overall relationship to cellular pathways/responses. 1 = miR-195, miR-424, miR-15a/b, and miR-497; 2 = miR-106a/b, miR-17, miR-20a/b, miR-93, and miR-519d; 3 = miR-124 and miR-506; 4 = miR-655, miR-548c-3p, and miR-101; 5 = miR-519a/b-3p/c-3p, miR-590-3p, and miR-513a-3p; 6 = miR-548n, miR-23a/b, and miR-27a/b; 7 = miR-548p and miR-429; and 8 = miR-548n and miR-27a/b.
Figure 3Graphical representation of the molecular relationships between oxidative stress-modulated miRNA gene targets. Indirect interactions exist between the protein products of the 13 gene targets of oxidative stress-modulated miRNAs predicted from our SID1.0 analysis (shown in Table 1). Molecules are represented as nodes, and the biological relationship between two nodes is represented as an edge (line). The dotted edges indicate indirect interactions whereas the others indicate direct interactions. All edges are supported by at least 1 reference from the literature, from a textbook, or from canonical information stored in the Ingenuity Pathways Knowledge Base. Nodes are displayed using various shapes that represent the functional class of the gene product, as indicated in the legend. The filled grey nodes indicate the 13 target molecules obtained from our SID1.0 analysis.
Figure 4Simplified overview of some of the effects that our identified oxidative stress-modulated miRNA gene targets may generate and their relation to protein ubiquitination.